Abcuro

record_type company
id 12331
name Abcuro
subtype Biotech / Pharma
metro_area —
hq_city —
hq_state —
website —
description Abcuro raised $66M in Series D funding to advance ulviprubart in an inclusion body myositis trial. NEA participated in the round alongsid...
founded_year —
data_confidence web_search
gov_entity_type —
sponsoring_agency —
sbir_award_count 0
sbir_total_usd —